Credit Suisse Healthcare
May have an interview with this group. Any insights regarding culture, pay, exit options, etc. would be appreciated.
Thanks in advance!
May have an interview with this group. Any insights regarding culture, pay, exit options, etc. would be appreciated.
Thanks in advance!
Career Resources
have a buddy who was in the group-- from what he says they're currently 3 in league tables, pretty ridiculous exit ops considering they all have placed for the past few years at funds like warburg, lindsay, tpg, silverlake, quadrangle, etc. overall quality of CS versus other top banks (i.e. GS, MS) is suspect, though.
I had the impression it was a pretty mediocre group (from a friend who worked at CS)... but if the exit opps mentioned above are true, then it's a ridiculous group...
While I can't comment on the exit opps specifically, I'm fairly certain CS is not #3 in league tables. Clearly depends on how you slice the pie w/ league tables, but I would definitely put CS's healthcare group in the middle tier of healthcare groups.
I agree with mid tier.
I agree with mid tier.
Do you guys have any insight on possible (specific) interview questions this group may ask?
CS Healthcare in San Fran (Originally Posted: 02/15/2011)
Does anyone know what their team is like? What kind of dealflow there is / where it came from?
bump
CS healthcare group - info please? (Originally Posted: 03/15/2012)
Anyone work there or have anecdotal insights they can share?
Looking to learn as much as I can relatively quickly.
PM or post, please.
SF or NYC?
SF
Is there a significant difference?
Sorry don't know SF group. I have a few friends in CS HC in NYC.
I think their experiences would clarify quite a bit for me. Is there anything you can share?
PM
Thanks for the anecdotal details, guys.
I'd really love to hear the opinions of someone who worked or is working in CS HC.
Bumping. Talking to them on Monday, so any info between now and then would help a ton
bump again!
CS Healthcare - How is the group regarded on the street? (Originally Posted: 01/14/2007)
I know they did HCA, but how is the group regarded on the street? Anyone know firsthand what the culture of the group is like?
I interviewed with the some people in the group earlier this fall. They have lost a lot of bankers to Lehman. They are sort of in rebuild phase. They have made some lateral hires and have gotten a few good people. I cannot say anything about the culture of the group, it is probably still developing.
CS Healthcare - Advising King Pharma on the LBO (Originally Posted: 10/21/2010)
Advising Genzyme, advising King Pharma on the LBO, etc.
How is this group?
very good group. i am also taking CS offer, did u get it through placement?
however in Sf they lost a deal team (md, vp, associate, analyst) to Citi about 3 months ago.
do you guys know how many analysts they're going to be hiring? SF office specifically...i have final rounds coming up thanks to a connection.
There is no CS healthcare in SF. The team that left was the last healthcare team there.
You have no idea what you're talking about, I know people in CS Healthcare in SF...
hi chanky, you get off work early
uhh..you seem to not know what you are talking about zirh..where did you get your source from?
CS HC is a pretty good group, definitely one of the better HC groups
CS HC in SF poached the old MS HC Menlo Park team - so yes, there is a SF HC team
I applied for an Analyst position at CS HC in SF within the last few months. So, yes. It exists.
They closed an SF health-care office back in '09, but seem to have reopened it this year after poaching an MD from Morgan Stanley. They've always been legit, pitching companies like Genentech, Gilead, Amgen, Celgene, etc.
The group still exists. Do you guys know anything specific about the group? Deal flow? Specifics about the industry prior to a interview?
CS SF Healthcare (Originally Posted: 05/26/2013)
Hi Monkeys,
I'm a sophomore studying Business + Pre-med and grew up in a family of doctors. So I have always had a passion for the sciences and medicine but am recently looking to do something more towards business and am looking to break into investment banking early in my career..
I was wondering if anyone has any insight into this group. Deal flow? Exit opps? # of bankers?
And how does CS HC compared to MS/JPM/GS. I know these three are probably the best but was wondering if CS Healthcare is just as competitive.
Thank you all!!
very small team. most deals are out of ny
Lollllll.. Couldn't be farther from the truth this guy doesn't know what he's saying.. CS SF is a deducted biotech/pharma team. That's why it's small.
They handle it all the execution. If you find an article on google they basically closed the most deals in biotech last year at $16BN. If you get that team you are in good shape if biotech is an interest.
However, personally GS and MS name brand might carry more but if you want good experience, deal flow and exposure then this team is solid.
bump.. would like to know more about the group
The MD in the SF office covering biotech/pharma has been doing very well. The CS brand still resonates well with PE shops and recruiters
http://www.institutionalinvestor.com/Stub.aspx?StubID=20635
MD came over from MS couple years back and is also Co-Head of America's Healthcare, small team and good deal flow. PM me if you wanna know more.
Hey archer,
Don't have enough points. Could you pm me instead?
oh ok. how's your internship going?
my internships going great. mind you tho i'm not in cs sf, only had an interview with them.
didnt realize you were a certified user. do you work with the HC team/CS? I could be wrong, but this is just the strong impression i got from interviewing with them.
just for further insight on this-- CS HC SF solely focuses on Biotech. Sit right next to the TMT guys from what I've heard. CS HC NY is everything else (managed care, life sciences, pharma, etc) & is also a good bit larger. Smart people on both coasts.
CS healthcare - Thoughts on the group? (Originally Posted: 12/15/2006)
anyone have any thoughts about CS healthcare group
the group is decent, but defintely not one of the best healthcare groups on the street. traditionally, the firm has been weak over the years, but had strong 2006 year. it worked on hca deal, but from what i heard, the only reason it was awarded that was because cs and ms were the only 2 bb's that didn't have conflict of interest and therefore were rewarded with fairness opinion mandate.
also advised bayer this year on its $16.5 billion acquisition.
which banks do you think have the best heathlcare groups right now?
1) UBS 2)JPM 3) GS
Healthcare at GS is good, but not as great as the other groups. However, GS name carries lot of weight.
what about Merrill?
Merrill had a monster year. UBS historically was the best, and still does pretty well, but its a sweatshop run by a shady guy everyone knows and has a terrible culture. JPM is dominant in HC, especially on the LevFin side and I would say is a close tie with Merill right now for first, although JPM lost some good people in the last year. GS is GS, they will be on a lot of the big HC M&A deals, not much financing
totally forgot about them, not sure why....yeah i'd day ML is defnitely up there in top 2......UBS hc culture blows though, ben lorello is a prick from people who have worked for him even at vp and director levels.....ubs usually gets lot of deals that other banks reject one way or the other....it is a sweatshop for sure as well.
I know for a fact that JPM HC lost 2 senior guys to CS, 2 to Lehman, and 3 to GS just in the past 7 months alone.
a megafund after UBS healthcare?
I am an analyst in a life science group (won't tell you where for obvious reasons. Strange that ppl on this board keep mentioning UBS as #1 in health care, since I've never heard of them as doing all that much relative to other groups.
If you look at the high profile Pharma M&A deals, UBS hasn't advised on any of the top 10 transactions all time. Looking at underwriting rankings in 2005 for Spec/Pharma and Biotech, UBS is third behind Cowen and CIBC...What am I missing here, why is UBS so great.
It's funny, I was talking to my VP about who he considers top banks in healthcare. He said Goldman, Lazard, JP Morgan, and Merrill.
What are the exit opportunities (b-school, PE, Healthcare VC, etc.) coming out of Goldman's Healthcare group?
Is the group itself well regarded (forgetting for a moment that it is under the GS brand name)?
Has anyone heard anything about the group in particular (lifestyle, hours, personalities of seniors, etc.)?
under Lorello has done a ton of deals and really dominiated the midmarket space, which was mostly services oriented, up until recently. They have fallen, but still do a good amount of deals.
GS HC is a good group, you'll get worked hard like any banking group, but your exit opps are still really good (people placed at TPG, KKR, Apollo, top hedge funds, etc) over last couple of years, if you want mega PE or HF, and you're good, you'll get placed (senior folks will put the calls in for you). You will do a lot of M&A in as the group historically focused on big pharma, but I hear that is chaning to get involved in more financing
look anywhere for the top HC bankers, and you will ALWAYS see Jim Forbes Head of HC at Merrill and Alan Hartman Head of HC M&A at Merrill (no, I don't work there). Right now, they're the dominant franchise on the street.
B of A did the lion's share of the financing for the HCA deal and several others, so, for Healthcare financing (at least debt financing) they're right up there with JPM. I wouldn't count their actual Healthcare advisory group as that great, though.
if i could go anywhere for hc it'd be 1. GS 2. ML
ML may be the hottest HC franchise right now, but Goldman will always be Goldman.
...maybe we're not looking at the same league tables? Oh well.
They give full-credit to all of the banks involved in a deal, no matter how far down the list of co-managers the bank was. So, Wachovia claims to somehow have been involved in HCA (I have no idea how they think they were involved if you search "Wachovia and HCA" on Wall St. Journal.com, nothing comes up, maybe they provided some of the debt financing) and on the league tables, they'll get full credit for the value of the deal - the same as, say, Citi gets, even though Citi was one of the original banks involved in the advisory part of the deal. League tables are useless - look at who's involved with what deals and, more importantly, what that bank's role is. Lead, joint, co-manager, it is all the same on the tables, but it makes a huge difference as far as the prestige of the industry coverage group.
Staying on GS Healthcare for a second, how does the exit opps and general prestige of the group compare to other GS groups?
Obviously, TMT would be tops, but what other groups are regarded more highly at GS?
Thanks for the input..
Working at a place that often gets screwed in league tables because of what you just mentioned, I certainly understand that. However, I don't get why everyone is so interested in debt financing. I also don't understand why seems to be viewing HCA as some sort of gold standard. Sure, it was a big deal...but c'mon, it was one deal.
I guess my view is, and I admittedly have my own biases, I'm interested in M&A. If you want to talk big M&A in life sciences, than a few posters perceptions are pretty far off in terms of which groups are "good."
Nusi,
So who is tops in healthcare M&A in you opinion? Was your post "entirely disagree" regarding Goldman or Merrill? I thought Goldman was big in healtcare M&A. Also, you mention Lazard, do you know what the exits are like out of Lazard healthcare? Thanks.
Lazard Life Sciences. Heard the exits out of there are pretty good. Any insight into the group?
No, I wish haha. I'm still in college!
I'm not here to bash anyone's shop, so perhaps I phrased some of my posts poorly. I just didn't understand the lovefest for UBS in healthcare. They have a great shop, and we all have heard how great their LA office places. But I just hadn't heard from anyone that worked in the field that they were a major player.
But I'm just a first year analyst can't say I'm an expert or anythig, so I am always open to new learning about other places.
I do know that Goldman is great for big pharma, obviously. They do all of J&J's stuff for instance. Merrill is great as well. If anyone wants to talk more, they can pm me...esp. since my associate is about done with this turn and maybe I can go home.
Fuga libero vitae et et quia laborum. Fugit dolores distinctio exercitationem enim dolorem aut libero.
In ad recusandae reiciendis distinctio magnam. Sequi tempore dolor hic placeat porro sed.
Illo quas fugiat impedit. Aperiam rerum necessitatibus perferendis eum et quidem culpa. Dolor molestiae voluptas aut dolores corrupti est. Consectetur exercitationem voluptatem ipsa.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...
Dolores aliquid quo rerum consequatur aliquid aut totam. Veritatis ut aut recusandae aliquid aut.
Dignissimos laborum quia quam ipsa impedit quasi. Aspernatur consequatur libero dolor minima in temporibus earum. Harum veniam enim debitis laboriosam magni animi molestias. Fugit eum autem eos expedita eos quisquam laudantium voluptas. Tenetur fuga est quam earum sunt nihil. Id qui non aut soluta et et.
Doloremque provident qui ut non ipsam et. Magnam quasi cum illum commodi itaque. Modi inventore impedit temporibus asperiores exercitationem quod sit occaecati.
Quia officiis doloremque ut ab explicabo aut omnis. In est et assumenda est dolore.
Aut animi modi animi ut. Ducimus non rerum labore deleniti saepe veritatis.
Ut voluptatem modi eius sit harum nihil. Dolore ea non ipsum et dolores est. In delectus eum libero est est qui in. Iste modi eos aperiam recusandae voluptas libero.
Qui non corrupti non harum laudantium debitis porro et. Nesciunt eum mollitia sit saepe. Cupiditate et fugit omnis et et sapiente.
Itaque maxime sed ea voluptatibus vel facere blanditiis ad. Repellat nulla id et maiores asperiores. Nemo sit totam eos ab laudantium possimus. Et eveniet praesentium laborum quia quis ducimus.
Dicta architecto non esse harum quo tempora. Voluptatem deserunt enim alias mollitia placeat. Temporibus expedita magnam aliquam saepe recusandae.